Most sold healthcare stocks in Q2 2025
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2025, measured as net reductions in reported share positions from Q1 2025 into Q2 2025. Notable reductions at the top of this list include HALEON PLC-ADR (HLN), NEKTAR THERAPEUTICS (NKTR), PFIZER INC (PFE), ORGANON & CO (OGN). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| HLN | HALEON PLC-ADR | -6,895,485 | -$57.63M | 1 | 4 | 4 | 1 | 10 |
| NKTR | NEKTAR THERAPEUTICS | -4,701,988 | -$3.20M | 0 | 0 | 0 | 2 | 0 |
| PFE | PFIZER INC | -4,156,615 | -$128.98M | 2 | 11 | 14 | 7 | 30 |
| OGN | ORGANON & CO | -4,009,874 | -$79.29M | 0 | 1 | 3 | 3 | 7 |
| MYGN | MYRIAD GENETICS INC | -3,778,493 | -$37.89M | 0 | 2 | 1 | 0 | 4 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -3,629,813 | $117.36M | 1 | 0 | 2 | 0 | 4 |
| OSCR | OSCAR HEALTH INC - CLASS A | -3,577,863 | -$26.42M | 4 | 3 | 2 | 1 | 10 |
| OCGN | OCUGEN INC | -3,459,283 | -$2.44M | 0 | 0 | 0 | 1 | 0 |
| ALHC | ALIGNMENT HEALTHCARE INC | -3,220,832 | -$71.52M | 0 | 2 | 0 | 2 | 2 |
| BBIO | BRIDGEBIO PHARMA INC | -3,218,775 | $50.92M | 2 | 0 | 2 | 0 | 4 |
| BMY | BRISTOL-MYERS SQUIBB CO | -3,217,596 | -$669.63M | 3 | 11 | 9 | 4 | 26 |
| TVTX | TRAVERE THERAPEUTICS INC | -2,809,622 | -$58.13M | 0 | 0 | 1 | 1 | 1 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -2,429,156 | -$26.41M | 2 | 0 | 6 | 2 | 9 |
| CI | THE CIGNA GROUP | -2,271,692 | -$731.01M | 0 | 8 | 7 | 2 | 18 |
| CVS | CVS HEALTH CORP | -2,126,904 | -$25.11M | 2 | 10 | 9 | 1 | 24 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,120,548 | -$150.90M | 1 | 7 | 5 | 2 | 15 |
| SENS | SENSEONICS HOLDINGS INC | -2,102,262 | -$1.87M | 0 | 0 | 1 | 1 | 1 |
| ENZ | ENZO BIOCHEM INC | -2,085,029 | -$771.46K | 0 | 0 | 0 | 2 | 0 |
| CERS | CERUS CORP | -2,040,714 | -$2.44M | 1 | 0 | 3 | 0 | 4 |
| GILD | GILEAD SCIENCES INC | -2,025,572 | -$274.64M | 3 | 11 | 6 | 4 | 20 |
| LYEL | LYELL IMMUNOPHARMA INC | -1,768,500 | -$951.45K | 0 | 0 | 0 | 1 | 0 |
| RXRX | RECURSION PHARMACEUTICALS-A | -1,767,120 | -$16.96M | 0 | 2 | 2 | 1 | 4 |
| QSI | QUANTUM-SI INC | -1,535,785 | $4.32M | 0 | 0 | 4 | 0 | 5 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -1,534,323 | -$8.58M | 0 | 0 | 1 | 0 | 1 |
| DVA | DAVITA INC | -1,354,098 | -$564.38M | 0 | 3 | 2 | 0 | 6 |
| SNY | SANOFI-ADR | -1,338,228 | -$596.85M | 1 | 9 | 3 | 1 | 13 |
| HOLX | HOLOGIC INC | -1,309,207 | -$70.07M | 1 | 4 | 4 | 4 | 10 |
| TRVI | TREVI THERAPEUTICS INC | -1,284,392 | -$9.75M | 0 | 1 | 1 | 0 | 2 |
| IMVT | IMMUNOVANT INC | -1,269,327 | -$21.96M | 0 | 0 | 1 | 1 | 1 |
| NVRO | NEVRO CORP | -1,209,409 | -$7.06M | 0 | 0 | 0 | 1 | 0 |
| NVS | NOVARTIS AG-SPONSORED ADR | -1,155,868 | -$3.99M | 1 | 5 | 4 | 1 | 13 |
| KRON | KRONOS BIO INC | -1,102,326 | -$909.42K | 0 | 0 | 0 | 1 | 0 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -1,053,937 | $41.80M | 0 | 1 | 2 | 0 | 3 |
| A | AGILENT TECHNOLOGIES INC | -1,039,486 | -$117.25M | 1 | 3 | 6 | 2 | 11 |
| PRME | PRIME MEDICINE INC | -1,020,525 | -$808.29K | 0 | 0 | 2 | 1 | 3 |
| OGI | ORGANIGRAM HOLDINGS INC | -1,004,748 | -$1.01M | 0 | 0 | 0 | 1 | 0 |
| SYK | STRYKER CORP | -1,002,479 | -$139.19M | 1 | 9 | 10 | 2 | 24 |
| VTYX | VENTYX BIOSCIENCES INC | -945,089 | -$1.02M | 0 | 0 | 1 | 0 | 1 |
| SOLV | SOLVENTUM CORP | -943,742 | $6.50M | 1 | 6 | 0 | 2 | 12 |
| ABSI | ABSCI CORP | -909,161 | -$1.68M | 0 | 0 | 1 | 0 | 1 |
| RPTX | REPARE THERAPEUTICS INC | -900,285 | -$676.30K | 0 | 1 | 0 | 1 | 1 |
| ALLK | ALLAKOS INC | -869,311 | -$197.85K | 0 | 0 | 0 | 1 | 0 |
| WRBY | WARBY PARKER INC-CLASS A | -856,799 | $27.71M | 0 | 1 | 3 | 1 | 5 |
| PAHC | PHIBRO ANIMAL HEALTH CORP-A | -805,592 | -$14.60M | 1 | 0 | 1 | 1 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -709,872 | -$29.32M | 2 | 1 | 3 | 2 | 7 |
| CMRX | CHIMERIX INC | -689,249 | -$5.87M | 0 | 0 | 0 | 1 | 0 |
| DCGO | DOCGO INC | -682,647 | -$2.20M | 0 | 0 | 1 | 1 | 2 |
| RAPT | RAPT THERAPEUTICS INC | -648,823 | -$791.56K | 0 | 0 | 0 | 1 | 0 |
| RLAY | RELAY THERAPEUTICS INC | -638,704 | -$297.98K | 2 | 0 | 1 | 0 | 3 |
| AGL | AGILON HEALTH INC | -625,909 | -$4.50M | 0 | 1 | 1 | 1 | 3 |
Frequently asked questions about Most sold healthcare stocks in Q2 2025
What are the most sold Healthcare stocks in Q2 2025?
The most sold healthcare stocks in Q2 2025 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2025?
Among filers in this sector, net reductions were largest in companies such as HALEON PLC-ADR (HLN), NEKTAR THERAPEUTICS (NKTR), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2025).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.